Search Results - "Guffanti, M."

A multidisciplinary effort to assign realistic source parameters to models of volcanic ash-cloud transport and dispersion during eruptions by Mastin, L.G., Guffanti, M., Servranckx, R., Webley, P., Barsotti, S., Dean, K., Durant, A., Ewert, J.W., Neri, A., Rose, W.I., Schneider, D., Siebert, L., Stunder, B., Swanson, G., Tupper, A., Volentik, A., Waythomas, C.F.

“…During volcanic eruptions, volcanic ash transport and dispersion models (VATDs) are used to forecast the location and movement of ash clouds over hours to days…”
Get full text

Volcanic-ash hazard to aviation during the 2003–2004 eruptive activity of Anatahan volcano, Commonwealth of the Northern Mariana Islands by Guffanti, Marianne, Ewert, John W., Gallina, Gregory M., Bluth, Gregg J.S., Swanson, Grace L.

“…Within the Commonwealth of the Northern Mariana Islands (CNMI), Anatahan is one of nine active subaerial volcanoes that pose hazards to major air-traffic…”
Get full text

Osteoprotegerin and bone turnover markers in heavily pretreated HIV‐infected patients by Seminari, E, Castagna, A, Soldarini, A, Galli, L, Fusetti, G, Dorigatti, F, Hasson, H, Danise, A, Guffanti, M, Lazzarin, A, Rubinacci, A

“…Objectives To characterize osteoprotegerin (OPG) levels, bone remodelling and bone mineral density (BMD) in heavily pretreated HIV‐infected patients on…”
Get full text

Cross–sectional and retrospective questionnaire-trial to evaluate exercise habits in a sample of HIV–infected individuals with type 2 diabetes mellitus by Codella, R., Guffanti, M., Castagna, A., Lazzarin, A., Luzi, L.

“…AbstractThe purpose of this observational and epidemiological study was to determine the quantity and quality of physical activity performed by 70 HIV–infected…”
Get full text

Cross–sectional and retrospective questionnaire-trial to evaluate exercise habits in a sample of HIV–infected individuals with type 2 diabetes mellitus by Codella, R, Guffanti, M, Castagna, A, Lazzarin, A, Luzi, L

“…AbstractThe purpose of this observational and epidemiological study was to determine the quantity and quality of physical activity performed by 70 HIV–infected…”
Get full text

Recombinant interleukin-2 for treatment of HIV reduces hepatitis C viral load in coinfected patients by UBERTI-FOPPA, C, DE BONA, A, MORSICA, G, GUFFANTI, M, GIANOTTI, N, BOERI, E, LAZZARIN, A

“…HIV infection modifies the course of hepatitis C virus (HCV) disease, and chronic HCV infection is becoming a growing cause of morbidity and mortality in…”
Get full text

Unusual Presentation of Cryptococcosis in a Patient with AIDS by Finazzi, R., Guffanti, M., Cernushi, M., Erembourg, L., Capasso, G., Ossi, C., Gesu, G.

Get full text

Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 by Spagnuolo, V., Guffanti, M., Galli, L., Poli, A., Querini, P. Rovere, Ripa, M., Clementi, M., Scarpellini, P., Lazzarin, A., Tresoldi, M., Dagna, L., Zangrillo, A., Ciceri, F., Castagna, A.

“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text

Effects of atazanavir/ritonavir and Iopinavir/ritonavir on glucose uptake and insulin sensitivity by Caumo, A, Guffanti, M, Perseghin, G, Galli, L, Lazzarin, A, Luzi, L, Castagna, A

“…We read with interest the article by Noor et al. examining the differential effects on glucose metabolism of the combinations of atazanavir/ritonavir versus…”
Get full text

Electrocardiographic changes in HIV-infected, drug-experienced patients being treated with atazanavir by GIANOTTI, Nicola, GUFFANTI, Monica, GALLI, Laura, MARGONATO, Alberto, CHIARAVALLI, Giulia, BIGOLONI, Alba, LAZZARIN, Adriano, CASTAGNA, Antonella

“…The QRS interval of 56 out of 75 (74.7%) HIV-infected, drug-experienced patients (66.7% men) increased during treatment with boosted or unboosted atazanavir by…”
Get full text

Benign-appearing mesothelioma cells in a serous effusion by Guffanti, M C, Faleri, M L

Get more information

Erratum to ‘A multidisciplinary effort to assign realistic source parameters to models of volcanic ash-cloud transport and dispersion during eruptions’ by Mastin et al. [J. Volcanol. Geotherm. Res. 188(2009)1–21] by Mastin, L.G., Guffanti, M., Servranckx, R., Webley, P., Barsotti, S., Dean, K., Durant, A., Ewert, J.W., Neri, A., Rose, W.I., Schneider, D., Siebert, L., Stunder, B., Swanson, G., Tupper, A., Volentik, A., Waythomas, C.F.

Get full text

Post-Kala-Azar Dermal Leishmaniasis in an HIV-1-Infected Woman: Recovery after Amphotericin B Following Failure of Oral Miltefosine by Guffanti, Monica, Gaiera, Giovanni, Bossolasco, Simona, Ceserani, Norberto, Ratti, Deborah, Cinque, Paola, Salmaso, Flavia, Gianotti, Nicola, Lazzarin, Adriano

“…We describe a case of post-kala-azar dermal leishmaniasis occurring after diagnosis of visceral leishmaniasis in an HIV-1-infected woman. The skin lesions did…”
Get full text

Prevalence of type 2 diabetes mellitus and its predictive factors in Italy: a comparison between HIV‐infected and uninfected subjects by Galli, L, Salpietro, S, Pellicciotta, G, Galliani, A, Piatti, PM, Hasson, H, Guffanti, M, Gianotti, N, Bigoloni, A, Lazzarin, A, Castagna, A

“…7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK…”
Get full text

A multidisciplinary effort to assign realistic source parameters to models of volcanic ash-cloud transport and dispersion during eruptions: Improved Prediction and Tracking of Volcanic Ash Clouds by MASTIN, L. G, GUFFANTI, M, SCHNEIDER, D, SIEBERT, L, STUNDER, B, SWANSON, G, TUPPER, A, VOLENTIK, A, WAYTHOMAS, C. F, SERVRANCKX, R, WEBLEY, P, BARSOTTI, S, DEAN, K, DURANT, A, EWERT, J. W, NERI, A, ROSE, W. I

Get full text

The 118I Reverse Transcriptase Mutation Is the Only Independent Genotypic Predictor of Virologic Failure to a Stavudine-Containing Salvage Therapy in HIV-1-Infected Patients by Gianotti, Nicola, Galli, Laura, Boeri, Enzo, De Bona, Anna, Guffanti, Monica, Danise, Anna, Salpietro, Stefania, Lazzarin, Adriano, Castagna, Antonella

“…Patients infected with HIV-1 with more than 1000 HIV-1 RNA copies/mL, who were genotyped within 3 months before starting stavudine and treated for at least 3…”
Get full text

Efficacy of Low-Dose Intermittent Subcutaneous Interleukin (IL)–2 in Antiviral Drug–Experienced Human Immunodeficiency Virus–Infected Persons with Detectable Virus Load: A Controlled Study of 3 IL-2 Regimens with Antiviral Drug Therapy by Tambussi, Giuseppe, Ghezzi, Silvia, Nozza, Silvia, Vallanti, Giuliana, Magenta, Lorenzo, Guffanti, Monica, Brambilla, Andrea, Vicenzi, Elisa, Carrera, Paola, Racca, Sara, Soldini, Laura, Gianotti, Nicola, Murone, Michelangelo, Veglia, Fabrizio, Poli, Guido, Lazzarin, Adriano

“…To evaluate the safety and efficacy of 3 regimens of intermittent subcutaneous (sc) interleukin (IL)–2 in a phase 2 study, 61 antiviral drug–experienced human…”
Get full text

Steady-state pharmacokinetics of atazanavir given alone or in combination with saquinavir hard-gel capsules or amprenavir in HIV-1-infected patients by SEMINARI, Elena, GUFFANTI, Monica, VILLANI, Paola, GIANOTTI, Nicola, CUSATO, Maria, FUSETTI, Giuliana, GALLI, Andrea, CASTAGNA, Antonella, REGAZZI, Mario, LAZZARIN, Adriano

“…The aim of this pilot study was to examine the pharmacokinetics of atazanavir (ATV) when given in combination with amprenavir (APV) or saquinavir hard-gel…”
Get full text

Pharmacokinetics of amprenavir given once or twice a day when combined with atazanavir in heavily pre-treated HIV-positive patients by GUFFANTI, Monica, DE PASCALIS, Cleta Raffaella, SEMINARI, E, FUSETTI, Giuliana, GIANOTTI, Nicola, BASSETTI, Dante, GALLI, Andrea, CASTAGNA, Antonella, LAZZARIN, Adriano

“…We studied the pharmacokinetics of amprenavir at doses of 600 mg twice a day or 1200 mg once a day, when co-administered to HIV-positive patients with 400 mg a…”
Get full text

Cytomegalovirus pneumonia in AIDS patients: value of cytomegalovirus culture from BAL fluid and correlation with lung disease by Uberti-Foppa, C, Lillo, F, Terreni, M R, Puglisi, A, Guffanti, M, Gianotti, N, Lazzarin, A

“…To verify the value of cytomegalovirus (CMV) cultures of BAL fluid vs postmortem lung histopathology in detecting CMV pneumonia, and to correlate the BAL viral…”
Get more information